Loading clinical trials...
Loading clinical trials...
A Phase I/II Study to Evaluate the Safety, Pharmacodynamics and Efficacy of Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
Conditions
Interventions
Atezolizumab
Bevacizumab
+1 more
Locations
4
United States
Indiana University Health Hospital
Indianapolis, Indiana, United States
Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
Ohio State University
Columbus, Ohio, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
June 29, 2017
Primary Completion Date
June 24, 2024
Completion Date
June 24, 2024
Last Updated
March 20, 2025
NCT07123090
NCT00026884
NCT04657068
NCT04585750
NCT07197671
NCT05831579
Lead Sponsor
Roberto Pili
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions